Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.

MLA

Lakhwani, Sunil, et al. “Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis in Newly Diagnosed Transplant-Eligible Myeloma Patients Complements the Prognostic Value of Minimal Residual Disease Detection.” Haematologica, vol. 109, no. 6, June 2024, pp. 1909–17. EBSCOhost, https://doi.org/10.3324/haematol.2023.284154.

APA

Lakhwani, S., Rosiñol, L., Puig, N., Pico-Picos, M.-A., Medina-González, L., Martínez-López, J., Paiva, B., Cedena, M.-T., Oriol, A., Ríos-Tamayo, R., Blanchard, M.-J., Jarque, I., Bargay, J., Moraleda, J.-M., Carrillo-Cruz, E., Sureda, A., Krsnik, I., González, E., Casado, L. F., … Hernández, M.-T. (2024). Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection. Haematologica, 109(6), 1909–1917. https://doi.org/10.3324/haematol.2023.284154

Chicago

Lakhwani, Sunil, Laura Rosiñol, Noemí Puig, Miguel-Angel Pico-Picos, Laura Medina-González, Joaquín Martínez-López, Bruno Paiva, et al. 2024. “Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis in Newly Diagnosed Transplant-Eligible Myeloma Patients Complements the Prognostic Value of Minimal Residual Disease Detection.” Haematologica 109 (6): 1909–17. doi:10.3324/haematol.2023.284154.